Target intelligence / Profile preview

Contactin-associated protein-like 4 (CNTNAP4)

Target
CNTNAP4
Molecular classification
Cell adhesion molecule, Transmembrane protein, Member of the neurexin superfamily, Receptor
01

Overview

Contactin-associated protein-like 4 (CNTNAP4) is a transmembrane protein of the neurexin superfamily that functions primarily as a cell adhesion molecule and receptor in the vertebrate nervous system[2][3][7]. It is characterized by multiple functional domains, including epidermal growth factor (EGF) repeats, laminin G domains, and other cell interaction motifs[2][3]. CNTNAP4 is involved in regulating synaptic development and neurotransmitter release, particularly affecting inhibitory (GABAergic) and dopaminergic signaling, and is implicated in the proper formation and function of neural circuits[1][3][7]. Pathogenic variations or dysregulation of this protein are associated with autism spectrum disorder, epilepsy, some psychiatric illnesses, and potentially bone developmental syndromes due to its interaction with ligands such as Neural EGFL-like 1 (Nell-1)[1][3][6]. As a synaptic cell adhesion molecule and emerging receptor, it represents a target of interest for neuropsychiatric and developmental research.

Other names
CASPR4KIAA1763cell recognition molecule Caspr4contactin associated protein family member 4
02

Biological functions

Cell adhesion in the nervous systemNeural developmentPresynaptic modulation of dopaminergic and GABAergic neurotransmissionStructural maturation of inhibitory interneuron synapses
03

Disease associations

Neurodevelopmental disorders (e.g., autism spectrum disorder)EpilepsyPotential role in Parkinson’s diseasePotential role in bone development disorders (osteogenesis, craniosynostosis, cleidocranial dysplasia)
04

Safety considerations

Potential link to psychiatric illness and neurodevelopmental disorders (mutations may impact neurological function)Disruption may alter neurotransmitter signaling, specifically dopamine and GABA

Beyond the preview

Go deeper on Contactin-associated protein-like 4 (CNTNAP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contactin-associated protein-like 4 (CNTNAP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call